These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37021333)

  • 1. Salivary levels of BAFF, TWEAK, and soluble CD163 and salivary arginase activity before and after periodontal treatment.
    Yilmaz M; Demir E; Gürsoy M; Firatli E; Loimaranta V; Gürsoy UK
    J Periodontal Res; 2023 Jun; 58(3):646-654. PubMed ID: 37021333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline interleukin-10, CD163, and tumor necrosis factor-like weak inducer of apoptosis (TWEAK) gingival tissue levels in relation to clinical periodontal treatment outcomes: A 12-week follow-up study.
    Yilmaz M; Demir E; Gürsoy M; Firatli E; Gürsoy UK
    J Periodontol; 2023 Jan; 94(1):141-154. PubMed ID: 35819128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saliva and serum levels of B-cell activating factors and tumor necrosis factor-α in patients with periodontitis.
    Gümüş P; Nizam N; Lappin DF; Buduneli N
    J Periodontol; 2014 Feb; 85(2):270-80. PubMed ID: 23701482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?
    Pers JO; d'Arbonneau F; Devauchelle-Pensec V; Saraux A; Pennec YL; Youinou P
    Arthritis Rheum; 2005 Aug; 52(8):2411-4. PubMed ID: 16052575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary and serum B-cell activating factor (BAFF) levels after hydroxychloroquine treatment in primary Sjögren's syndrome.
    Mumcu G; Biçakçigil M; Yilmaz N; Ozay H; Karaçayli U; Cimilli H; Yavuz S
    Oral Health Prev Dent; 2013; 11(3):229-34. PubMed ID: 23878841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arginine-nitric oxide-polyamine metabolism in periodontal disease.
    Ozer L; Elgun S; Ozdemir B; Pervane B; Ozmeric N
    J Periodontol; 2011 Feb; 82(2):320-8. PubMed ID: 20831369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periodontal therapy reduces arginase activity in saliva of patients with chronic periodontitis.
    Gheren LW; Cortelli JR; Rodrigues E; Holzhausen M; Saad WA
    Clin Oral Investig; 2008 Mar; 12(1):67-72. PubMed ID: 17701233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of soluble CD163 in periodontitis patients.
    Detzen L; Chen SCY; Cheng B; Papapanou PN; Lalla E
    J Clin Periodontol; 2017 Jun; 44(6):585-590. PubMed ID: 28419494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salivary Biomarkers in Periodontitis Post Scaling and Root Planing.
    Priya KL; Mahendra J; Mahendra L; Kanakamedala A; Alsharif KF; Mugri MH; Varadarajan S; Alamoudi A; Hassan AAA; Alnfiai MM; Alzahrani KJ; Bahammam MA; Baeshen HA; Balaji TM; Bhandi S
    J Clin Med; 2022 Dec; 11(23):. PubMed ID: 36498715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement split product C3c in saliva as biomarker for periodontitis and response to periodontal treatment.
    Grande MA; Belstrøm D; Damgaard C; Holmstrup P; Thangaraj SS; Nielsen CH; Palarasah Y
    J Periodontal Res; 2021 Jan; 56(1):27-33. PubMed ID: 32681659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salivary arginase in patients with adult periodontitis.
    Ozmeriç N; Elgün S; Uraz A
    Clin Oral Investig; 2000 Mar; 4(1):21-4. PubMed ID: 11218511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of salivary arginine catabolic activity through periodontal therapy.
    Pereira AL; Cortelli SC; Aquino DR; Franco GC; Cogo K; Rodrigues E; Costa FO; Holzhausen M; Cortelli JR
    Quintessence Int; 2012 Oct; 43(9):777-87. PubMed ID: 23041992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of non-surgical periodontal treatment on salivary and serum biomarkers in Stage III Grade B and C periodontitis.
    Görgülü NG; Doğan B
    J Periodontol; 2022 Aug; 93(8):1191-1205. PubMed ID: 35043972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio.
    Moreno JA; Dejouvencel T; Labreuche J; Smadja DM; Dussiot M; Martin-Ventura JL; Egido J; Gaussem P; Emmerich J; Michel JB; Blanco-Colio LM; Meilhac O
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1253-62. PubMed ID: 20299688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
    Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B cell activating factor regulates periodontitis development by suppressing inflammatory responses in macrophages.
    Wang L; Zhang T; Zhang Z; Wang Z; Zhou YJ; Wang Z
    BMC Oral Health; 2021 Sep; 21(1):426. PubMed ID: 34481478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.
    Kowal-Bielecka O; Bielecki M; Guiducci S; Trzcinska-Butkiewicz B; Michalska-Jakubus M; Matucci-Cerinic M; Brzosko M; Krasowska D; Chyczewski L; Kowal K
    Arthritis Res Ther; 2013; 15(3):R69. PubMed ID: 23800379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary IL-33 and sST2 levels in relation to TLR2 rs111200466 polymorphism and periodontitis.
    Yilmaz M; He Q; Demir E; Teräsjärvi J; Gürsoy UK
    Oral Dis; 2024 May; 30(4):2254-2261. PubMed ID: 37427857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of scaling and root planing on salivary and serum fetuin-A levels in patients with Stages II and III periodontitis.
    Nair S; Nisha KJ
    J Periodontol; 2022 Feb; 93(2):177-186. PubMed ID: 33997977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker panel discriminates diabetics with and without periodontitis pre- and post-therapy.
    Miller CS; Ding X; Nagarajan R; Dawson DR; Ebersole JL
    J Periodontal Res; 2023 Jun; 58(3):493-502. PubMed ID: 37042710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.